课题基金 / 基金详情

MECHANISMS OF NEUROENDOCRINE LUNG CARCINOGENESIS

MECHANISMS OF NEUROENDOCRINE LUNG CARCINOGENESIS
神经内分泌肺癌的发生机制
批准号:
3509571
负责人:
Hildegard M. Schuller
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 1993-09-29

项目摘要

项目成果

Hildegard M. Schuller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a Shannon Award providing partial support for research projects that fall short of the assigned institute's funding range but are in the margin of excellence. The Shannon award is intended to provide support to test the feasibility of the approach; develop further tests and refine research techniques; perform secondary analysis of available data sets; or conduct discrete projects that can demonstrate the PI's research capabilities or lend additional weight to an already meritorious application. Further scientific data for the CRISP System are unavailable at this time.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways.
二氧化碳通过刺激自分泌和蛋白激酶 C 依赖性有丝分裂途径,增强尼古丁及其致癌衍生物 NNK 在正常和肿瘤性神经内分泌肺细胞中的促有丝分裂作用。
DOI: --
发表时间: 1994
期刊: Neurotoxicology
影响因子: 3.4
作者: [Schuller,HM]
通讯作者: Schuller,HM
Inhibition of protein-kinase-C--dependent cell proliferation of human lung cancer cell lines by the dihydropyridine dexniguldipine.
二氢吡啶右尼古地平对人肺癌细胞系蛋白激酶 C 依赖性细胞增殖的抑制作用。
DOI: 10.1007/bf01247460
发表时间: 1994
期刊: Journal of cancer research and clinical oncology
影响因子: 3.6
作者: [Schuller,HM, Orloff,M, Reznik,GK]
通讯作者: Reznik,GK
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8064258
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
Modulation of cancer prevention by social stress
  • 批准号:
    7809021
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    8252196
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
  • 批准号:
    7714157
  • 项目类别:
  • 资助金额:
    $27.27万
  • 财政年份:
    2009
  • 负责人:
    Hildegard M. Schuller
  • 依托单位:
海外基金